Pharma
CPhI and Informa Pharma Intelligence Concluded the 3rd Biopharma Conclave
Scientific R&D Underway for Therapeutic Antibodies Against COVID-19 by DBT/ Anti-COVID Consortium
Reinventing the Indian pharma business is no longer a choice but an imperative: EY report
Pfizer to Diversify Into Hospital Business, Would Also Split into Three Business Segments
Suresh Prabhu Appealed Pharma Companies to Explore New Markets, More R&D
/smstreet/media/agency_attachments/3LWGA69AjH55EG7xRGSA.png)
/smstreet/media/media_files/2025/03/26/ZdfgMLwkTcXPQGDaYoEl.jpg)
/smstreet/media/post_banners/wl3I1bljZ3KrppuiQywP.jpg)
/smstreet/media/post_banners/4YcsuXQ08y9jZROoFxUy.jpg)
/smstreet/media/post_banners/zlGkovEWx3MGIRwDgsIx.jpg)
/smstreet/media/post_banners/M0t4QXMHESCeOnlrxo1e.jpg)
/smstreet/media/post_banners/JZJA9zF3iGNunGyrm985.jpg)
/smstreet/media/post_banners/XzRH3CTEGBLc7ZXSNvGn.jpg)
/smstreet/media/post_banners/OCBY37ejpJTedw6VhqkT.jpg)
/smstreet/media/post_banners/z9M8rz8IS6B52iC8XO8A.jpg)
/smstreet/media/post_banners/bV0580odrkHkf7btderB.jpg)
